$AMPH news
The latest AMPH stock news: headlines, filings, AI summaries and sentiment for $AMPH, updated around the clock.
- Amphastar Reports Q3 2026 Revenue Growth Driven by BAQSIMI and Primatene MIST Sales
- Amphastar Pharmaceuticals, Inc. - 10-Q Filing
- Amphastar Pharmaceuticals Reports Q3 Earnings Beat on Revenue and EPS
- Amphastar Pharmaceuticals, Inc. - 8-K Filing
- Amphastar Pharmaceuticals Announces Q3 2026 Earnings Release Date
- Amphastar Pharmaceuticals, Inc. - 8-K Filing
- Amphastar Pharmaceuticals, Inc. - 8-K Filing
- Amphastar Pharmaceuticals, Inc. - 8-K Filing
- Piper Sandler Lowers Price Target for Amphastar Pharmaceuticals to $21 Amid Pipeline Uncertainty
- Wells Fargo Lowers Amphastar Pharmaceuticals' Price Target to $19
- Amphastar Reports Q1 2026 Earnings with Mixed Performance Across Product Lines
- Amphastar Pharmaceuticals, Inc. - 10-Q Filing
- Amphastar Pharmaceuticals, Inc. - 8-K Filing
- Jefferies Downgrades Amphastar Pharmaceuticals (AMPH) Due to Lack of Upside Catalysts
- Amphastar Pharmaceuticals Discusses Baqsimi and Primatene Growth at Needham Conference